Kei Kishimoto

Kei Kishimoto

Company: Selecta Biosciences Inc.

Job title: Chief Scientific Officer


Translating Antigen-Specific Immune Tolerance Approaches to Mitigate Immunogenicity of Biologic Therapies 2:35 pm

Dive into harnessing antigen-specific immune tolerance strategies and expertise to inhibit unwanted immune responses against protein and enzyme therapies, AAV gene therapies, and more. Capitalize on your antigen-specific autoimmune tolerance approaches and capture this opportunity at your fingertips. Understanding which cell populations become tolerized in drug-specific tolerance approaches Discussing pros and cons of applying antigen-specific…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.